// June 26, 2023
Complex generics: Are global regulators addressing the needs?
The development of generic versions of innovator medicines is a global public health need.
The development of generic versions of innovator medicines is a global public health need.
In the U.S. and around the world, quality standards developed by the U.S.
For patients needing a bone marrow or stem cell transplant, successful treatment often depends on
In conversations about the role of quality standards in public health, you might come across the